ALLG and MRFF via CanTeen launch new clinical trial to improve the lives of young AustraliansAugust 2018On Wednesday 25 July, Federal Health Minister Greg Hunt announced $3.2 million in funding to four clinical trials that will give [...]
Mr Peter Terence Kempen – Honorary Member in the General Division (AM)June 2018On Monday 11 June, the Chairman of the ALLG, Mr Peter T Kempen was announced as an honorary Member (AM) in the general division of the [...]
May 2018 ALLG Scientific Meeting HighlightsMay 2018The Australasian Leukaemia and Lymphoma Group (ALLG) held its May 2018 Scientific Meeting (SM) in Melbourne with 270 members in attendance.
Where to now for the Medical Research Future Fund (MRFF)?April 2018Late last year the ALLG welcomed the release of the Select Committee report into Funding for Research into Cancers with Low Survival [...]
The Importance of Clinical TrialsFebruary 2018This year, almost 16,000 Australians will begin a long and gruelling journey with blood cancer. Decades of research have led to vastly [...]
ALLG Trials Newsletter No. 17 – February 2018February 2018This newsletter is published approximately every two months and provides update information on the ALLG trial program. Other ALLG [...]
Senate Report: Funding for Research into Cancers with Low Survival RatesJanuary 2018The Australasian Leukaemia & Lymphoma Group (ALLG) welcomed the November 2017 release of the Select Committee Report into funding for [...]
Professor Mark Hertzberg – Seven Years at the HelmDecember 2017Professor Mark Hertzberg recently retired as Chair of The Australasian Leukaemia & Lymphoma Group (ALLG) Scientific Advisory Committee [...]
Australasian Leukaemia and Lymphoma Group is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity.
Memberships
Donations
Clinical Trials & Research